Caladrius Biosciences, Inc. (LSTA) Tops Q3 EPS by 10c

Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q3 EPS of ($0.49), $0.10 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.

You May Also Be Interested In

• Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
• Musalem: strong growth and investment influencing bond market - CNBC
• Meritage Homes Corporation (MTH) Declares $0.48 Quarterly Dividend; 2.7% Yield